More on ARMP
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $10.96 |
|
|||
| Open | $10.81 | ||||
| 52 Wk High | $2.00 | ||||
| 52 Wk Low | $1.50 | ||||
| Day High | $11.33 | ||||
| Day Low | $9.99 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 37,154 | ||||
- Armata Pharmaceuticals (ARMP) PT Lowered to $15 at H.C. Wainwright
- Form 8-K Armata Pharmaceuticals, For: Feb 23
- Armata Pharmaceuticals receives FDA QIDP designation for AP-SA02
- Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02
- Form SCHEDULE 13D/A Armata Pharmaceuticals, Filed by: Innoviva, Inc.
- Form 8-K Armata Pharmaceuticals, For: Jan 26
- Form 8-K Armata Pharmaceuticals, For: Jan 13
- Armata Pharmaceuticals gets FDA clearance for phase 3 bacteriophage study
- Armata Pharmaceuticals Announces End-of-Phase 2 Meeting with FDA and Plans to Advance AP-SA02 to a Phase 3 Superiority Study in Complicated BacteremiaStaphylococcusaureus
- Jones Trading Starts Armata Pharmaceuticals (ARMP) at Buy
Entities mentioned with ARMP
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Ladenburg Thalmann Financial Services | View Related Stories »
- 13D | View Related Stories »
- Show More...
